Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 15 December 2020. Jessica Schubel.

Executive Summary

Experts speculate a Good Guidance Practices regulation from the US HHS will delight the medtech industry but see FDA pushback. Jessica Schubel, a senior policy analyst for the Center on Budget and Policy Priorities, expressed concerns.

"I think everyone is a loser in terms of having this reg finalized, because it’s implementing a process that is totally unnecessary.” – Jessica Schubel, senior policy analyst, Center on Budget and Policy Priorities

Click here for a free trial of Medtech Insight

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts